Key result
Tumor stage was the only independent prognostic factor for survival, with 5-year survival rates of 100% in stage I, 85% in stage II, 40% in stage III, and 0% in stage IV.
Authors
Loading...
Tumor stage guides prognosis in this cohort; leaves open whether stage-directed therapies alter survival in prospective trials.
Cohort (n=34)
Tucci et al. (2005) conducted a cohort in adrenocortical carcinoma (n=34). Tumor stage was evaluated on 5-year survival. Tumor stage was the only independent prognostic factor for survival, with 5-year survival rates of 100% in stage I, 85% in stage II, 40% in stage III, and 0% in stage IV.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: